Consecutive Low Doses of Streptozotocin Induce Polycystic Ovary Syndrome Features in Mice

Polycystic ovarian syndrome (PCOS) is a common reproductive endocrine disorder in reproductive-age women. Due to its various pathophysiological properties and clinical heterophenotypes, the mechanism of PCOS pathogenesis is still unclear. Several animal models have been used to study PCOS and allow...

Full description

Bibliographic Details
Main Authors: Youngjae Ryu, Yong Jin Kim, Yoon Young Kim, Jungwoo Kim, Sung Woo Kim, Hoon Kim, Seung Yup Ku
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/3/1299
_version_ 1797406337648295936
author Youngjae Ryu
Yong Jin Kim
Yoon Young Kim
Jungwoo Kim
Sung Woo Kim
Hoon Kim
Seung Yup Ku
author_facet Youngjae Ryu
Yong Jin Kim
Yoon Young Kim
Jungwoo Kim
Sung Woo Kim
Hoon Kim
Seung Yup Ku
author_sort Youngjae Ryu
collection DOAJ
description Polycystic ovarian syndrome (PCOS) is a common reproductive endocrine disorder in reproductive-age women. Due to its various pathophysiological properties and clinical heterophenotypes, the mechanism of PCOS pathogenesis is still unclear. Several animal models have been used to study PCOS and allow the exploration of the specific mechanism underlying PCOS. We focused on streptozotocin (STZ) to develop a non-steroidal and non-diabetic PCOS model. We administered multiple STZ injections to female C57BL/6 mice (3–4 weeks old) at different concentrations: STZ-15 (15 mg/kg), STZ-30 (30 mg/kg), and STZ-60 (60 mg/kg) treatments. During the experimental period, we analyzed body weight, blood glucose levels, and estrous cycle pattern. Furthermore, five weeks after STZ administration, we examined hormone levels and the morphology of ovarian tissues. Mice in the STZ-15 group did not show differences in body weights, blood glucose level, insulin level, and insulin tolerance compared to wild-type and control groups whereas those in the STZ-60 group presented a typical diabetes phenotype. In the case of the STZ-30 group, only increased blood glucose level was observed. Total testosterone levels were significantly elevated in STZ-15 and STZ-30 groups. Luteinizing hormone (LH) and estradiol levels were not significantly changed in the STZ-treated groups. The number of ovarian antral follicles and atretic follicles significantly increased in the ovary of mice in the STZ-15 and STZ-30 groups. All STZ-treated groups manifested irregular estrus cycles. However, the patterns of estrous cycles were different between mice treated with different STZ concentrations. We found that PI3K-AKT and IRS-1 signaling in the ovary was enhanced by low doses of STZ treatment. Taken together, our finding indicates that multiple injections of STZ at low doses induce PCOS features in mice without induction of diabetes features.
first_indexed 2024-03-09T03:24:56Z
format Article
id doaj.art-e7a158f1e6c747728724ca21c7247d6e
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T03:24:56Z
publishDate 2021-01-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-e7a158f1e6c747728724ca21c7247d6e2023-12-03T15:04:04ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-01-01223129910.3390/ijms22031299Consecutive Low Doses of Streptozotocin Induce Polycystic Ovary Syndrome Features in MiceYoungjae Ryu0Yong Jin Kim1Yoon Young Kim2Jungwoo Kim3Sung Woo Kim4Hoon Kim5Seung Yup Ku6Biomedical Research Institute, Seoul National University Hospital, Seoul 03080, KoreaDepartment of Obstetrics and Gynecology, Korea University College of Medicine, Seoul 02841, KoreaBiomedical Research Institute, Seoul National University Hospital, Seoul 03080, KoreaInstitute of Reproductive Medicine and Population, Medical Research Center, Seoul National University College of Medicine, Seoul 03080, KoreaDepartment of Obstetrics and Gynecology, Seoul National University Hospital, Seoul 03080, KoreaDepartment of Obstetrics and Gynecology, Seoul National University Hospital, Seoul 03080, KoreaInstitute of Reproductive Medicine and Population, Medical Research Center, Seoul National University College of Medicine, Seoul 03080, KoreaPolycystic ovarian syndrome (PCOS) is a common reproductive endocrine disorder in reproductive-age women. Due to its various pathophysiological properties and clinical heterophenotypes, the mechanism of PCOS pathogenesis is still unclear. Several animal models have been used to study PCOS and allow the exploration of the specific mechanism underlying PCOS. We focused on streptozotocin (STZ) to develop a non-steroidal and non-diabetic PCOS model. We administered multiple STZ injections to female C57BL/6 mice (3–4 weeks old) at different concentrations: STZ-15 (15 mg/kg), STZ-30 (30 mg/kg), and STZ-60 (60 mg/kg) treatments. During the experimental period, we analyzed body weight, blood glucose levels, and estrous cycle pattern. Furthermore, five weeks after STZ administration, we examined hormone levels and the morphology of ovarian tissues. Mice in the STZ-15 group did not show differences in body weights, blood glucose level, insulin level, and insulin tolerance compared to wild-type and control groups whereas those in the STZ-60 group presented a typical diabetes phenotype. In the case of the STZ-30 group, only increased blood glucose level was observed. Total testosterone levels were significantly elevated in STZ-15 and STZ-30 groups. Luteinizing hormone (LH) and estradiol levels were not significantly changed in the STZ-treated groups. The number of ovarian antral follicles and atretic follicles significantly increased in the ovary of mice in the STZ-15 and STZ-30 groups. All STZ-treated groups manifested irregular estrus cycles. However, the patterns of estrous cycles were different between mice treated with different STZ concentrations. We found that PI3K-AKT and IRS-1 signaling in the ovary was enhanced by low doses of STZ treatment. Taken together, our finding indicates that multiple injections of STZ at low doses induce PCOS features in mice without induction of diabetes features.https://www.mdpi.com/1422-0067/22/3/1299polycystic ovary syndromestreptozotocinanimal modelsovarytestosterone
spellingShingle Youngjae Ryu
Yong Jin Kim
Yoon Young Kim
Jungwoo Kim
Sung Woo Kim
Hoon Kim
Seung Yup Ku
Consecutive Low Doses of Streptozotocin Induce Polycystic Ovary Syndrome Features in Mice
International Journal of Molecular Sciences
polycystic ovary syndrome
streptozotocin
animal models
ovary
testosterone
title Consecutive Low Doses of Streptozotocin Induce Polycystic Ovary Syndrome Features in Mice
title_full Consecutive Low Doses of Streptozotocin Induce Polycystic Ovary Syndrome Features in Mice
title_fullStr Consecutive Low Doses of Streptozotocin Induce Polycystic Ovary Syndrome Features in Mice
title_full_unstemmed Consecutive Low Doses of Streptozotocin Induce Polycystic Ovary Syndrome Features in Mice
title_short Consecutive Low Doses of Streptozotocin Induce Polycystic Ovary Syndrome Features in Mice
title_sort consecutive low doses of streptozotocin induce polycystic ovary syndrome features in mice
topic polycystic ovary syndrome
streptozotocin
animal models
ovary
testosterone
url https://www.mdpi.com/1422-0067/22/3/1299
work_keys_str_mv AT youngjaeryu consecutivelowdosesofstreptozotocininducepolycysticovarysyndromefeaturesinmice
AT yongjinkim consecutivelowdosesofstreptozotocininducepolycysticovarysyndromefeaturesinmice
AT yoonyoungkim consecutivelowdosesofstreptozotocininducepolycysticovarysyndromefeaturesinmice
AT jungwookim consecutivelowdosesofstreptozotocininducepolycysticovarysyndromefeaturesinmice
AT sungwookim consecutivelowdosesofstreptozotocininducepolycysticovarysyndromefeaturesinmice
AT hoonkim consecutivelowdosesofstreptozotocininducepolycysticovarysyndromefeaturesinmice
AT seungyupku consecutivelowdosesofstreptozotocininducepolycysticovarysyndromefeaturesinmice